Frederick S. Jones

Sysmex (Japan)

Papers

2

Total Citations

52

H-Index

2

About

No biography available yet.

Research Focus

Key Achievements

2
H-Index
2
Papers
52
Total Citations
26
Avg Citations/Paper
🏆 Most Cited Paper
Neoadjuvant Nivolumab Plus Chemotherapy Followed By Response-Adaptive Therapy for HPV<sup>+</sup> Oropharyngeal Cancer
45 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 25
🏛 Institutions: Sysmex (Japan)

Top Papers

  1. 1
  2. 2

Key Collaborators

Not generated yet